Category:



  • 19Aug

    BETHESDA, Md., Aug. 19 /PRNewswire-FirstCall/ — DiamondRock Hospitality
    Company (NYSE: DRH) today announced that it will pay a dividend of $0.25 per
    share to its common shareholders of record as of September 5, 2008. This
    dividend will be paid on September 16, 2008.

    (Logo: http://www.newscom.com/cgi-bin/prnh/20040708/DCTH028 )

    About DiamondRock Hospitality Company

    DiamondRock Hospitality Company is a self-advised real estate investment
    trust (REIT) that is an owner of premium hotel properties. DiamondRock owns
    20 hotels with approximately 9,600 rooms. For further information, please
    visit DiamondRock’s website at www.drhc.com.

    SOURCE DiamondRock Hospitality Company

  • 19Aug

    WILTON, Conn., Aug. 19 /PRNewswire/ — Onward Healthcare
    (http://www.onwardhealthcare.com) is pleased to announce that it has earned
    recertification for the Gold Seal of Approval(TM) for healthcare staffing
    services by The Joint Commission. The Gold Seal acknowledges compliance with
    The Joint Commission’s national set of consensus-based quality standards and
    demonstrates a commitment to excellence in providing healthcare staffing.

    Over the past decade, the ongoing shortages of nurses and allied health
    care professionals have forced healthcare organizations to increasingly fill
    positions with temporary workers through contractual arrangements with travel
    nursing and related staffing firms. The Joint Commission’s certification
    program, launched in October 2004, offers an independent, comprehensive
    evaluation of a staffing firm’s abilities to provide competent staffing
    services.

    The Joint Commission recently completed an unannounced, on-site review of
    Onward Healthcare and its compliance with their organization and quality
    management standards. These standards address how a healthcare staffing firm
    determines the qualifications and competencies of their staff, recruits and
    retains healthcare professionals, enacts emergency management procedures, and
    supports their healthcare clients by managing a comprehensive quality
    management process.

    “The Joint Commission’s external review of our operations validates our
    ongoing commitment to our clients, as well as our thousands of healthcare
    professionals across the country,” stated Kevin Clark, CEO and founder of
    Onward Healthcare. “The Gold Seal demonstrates our commitment to the highest
    standards of patient care, which we have achieved through innovative practice
    changes designed to raise the bar in our industry.”

    In 2005, Onward Healthcare was one of the first companies to receive full
    certification by The Joint Commission for its travel nursing, local nursing,
    and allied health staffing services. In addition to the renewed recognition
    for its travel and local nursing and allied services, Onward has also received
    certification for its clinical research services (CRS) division which launched
    in November of 2007. Organizations in the pharmaceutical, biotechnology,
    medical device, and related clinical research industries can now be assured
    the same high caliber of professionals when looking to Onward for their
    staffing needs.

    “Healthcare organizations that contract with Onward Healthcare can look to
    this certification as an assurance that their entire organization demonstrates
    a commitment to providing and continuously improving quality services,” says
    Michele Sacco, M.S., executive director, Health Care Staffing Services
    Certification, Joint Commission.

    The Joint Commission’s review process focuses on an organization’s ability
    to provide competent staffing services and evaluates performance, continuing
    education and training, placement criteria, and other areas. Furthermore,
    they look for excellence in the areas of leadership, human resources
    management, performance measurement and improvement, and information
    management.

    About Onward Healthcare

    Onward Healthcare (http://www.onwardhealthcare.com/company/about.aspx) is
    a leading provider of integrated travel and local per diem staffing for
    registered nurses, allied health professionals, clinical research
    professionals, international candidates and vendor managed services for large
    health systems. Onward currently staffs clients in all 50 states including
    hospitals, outpatient clinics, magnet facilities, government facilities,
    schools, and long-tem care facilities. Founded in 2002, Onward Healthcare is
    headquartered in Wilton, CT with local staffing offices in Encinitas, CA,
    Burlington, MA, Crofton, MD, Cherry Hill, NJ, Livingston, NJ, Melville, NY,
    and Wexford, PA.

    About The Joint Commission

    Founded in 1951, The Joint Commission seeks to continuously improve the
    safety and quality of care provided to the public through the provision of
    health care accreditation and related services that support performance
    improvement in health care organizations. The Joint Commission evaluates and
    accredits more than 15,000 health care organizations and programs in the
    United States, including more than 8,000 hospitals and home care
    organizations, and more than 6,800 other health care organizations that
    provide long term care, assisted living, behavioral health care, laboratory
    and ambulatory care services. The Joint Commission also accredits health
    plans, integrated delivery networks, and other managed care entities. In
    addition, The Joint Commission provides certification of disease-specific care
    programs, primary stroke centers, and health care staffing services. An
    independent, not-for-profit organization, the Joint Commission is the nation’s
    oldest and largest standards-setting and accrediting body in health care.
    Learn more about The Joint Commission at www.jointcommission.org.

    SOURCE Onward Healthcare

  • 19Aug

    Free White Canes to be Provided Nationwide

    BALTIMORE, Aug. 19 /PRNewswire-USNewswire/ — The National Federation of the Blind (NFB), the nation’s oldest and largest organization of blind people, today announced an initiative to ensure that any blind person in the United States and Puerto Rico who needs a long white cane will have one, regardless of ability to pay. The NFB will provide a free cane to anyone in the fifty states, the District of Columbia, or Puerto Rico who is blind or has low vision and who uses or desires to use a white cane in order to travel independently. This historic initiative is the largest effort ever of its kind to provide white canes to individuals who are blind or have low vision.

    “The white cane is both a symbol of and a tool for independence,” said Dr. Marc Maurer, President of the National Federation of the Blind. “It allows blind individuals to travel whenever and wherever they want, leading to self-confidence and self-sufficiency. With the initiation of this landmark program by the National Federation of the Blind, every blind person who wants the freedom and mobility that a white cane provides can have it.”

    The long white cane provides an effective means for blind students to get to school, blind adults to get to work, and blind seniors to remain active. Art Schreiber, a retired broadcaster from Albuquerque, New Mexico, said: “As an active blind person and someone who has traveled throughout the world, I know the white cane means freedom for blind seniors everywhere.”

    Melissa Riccobono, a blind stay-at-home mom and educational consultant said: “As the mother of an active twenty-month-old son, my cane helps me to safely navigate through my busy day from walking to the playground to visiting the pediatrician.”

    It is estimated that 109,000 of the 1.3 million legally blind people in the United States use a white cane. By supplying canes free of charge, this program provides the opportunity for all blind Americans to have a white cane and to participate fully in society.

    The National Federation of the Blind will provide a straight, light fiberglass cane to any blind individual in the United States or Puerto Rico who requires the cane for personal use. Canes are available in the following lengths: 53, 55, 57, 59, 61, or 63 inches. Individuals may only request one free cane in any six-month period. For more information on the use of the long white cane and the National Federation of the Blind free cane program, please visit www.nfb.org.

    About the National Federation of the Blind

    With more than 50,000 members, the National Federation of the Blind is the largest and most influential membership organization of blind people in the United States. The NFB improves blind people’s lives through advocacy, education, research, technology, and programs encouraging independence and self-confidence. It is the leading force in the blindness field today and the voice of the nation’s blind. In January 2004 the NFB opened the National Federation of the Blind Jernigan Institute, the first research and training center in the United States for the blind led by the blind.

    CONTACT:
    Chris Danielsen
    Public Relations Specialist
    National Federation of the Blind
    (410) 659-9314, extension 2330
    (410) 262-1281(Cell)
    cdanielsen@nfb.org

    SOURCE National Federation of the Blind

  • 19Aug

    MUMBAI, India and BALTIMORE, Aug. 19 /PRNewswire/ — Lupin Ltd. announced
    today that the Company has entered into a multi-year promotion and marketing
    agreement for the AeroChamber Plus(R) line of products with Forest
    Laboratories, Inc. Under the terms of the agreement, Lupin Pharmaceuticals,
    Inc., USA, will use its 50 person sales force to promote the product to
    pediatricians.

    AeroChamber Plus(R) is a Valved Holding Chamber (VHC) device that is used
    with metered dose inhalers to improve the delivery of medication to the lungs
    in the treatment of asthma and COPD. AeroChamber Plus(R) also reduces the
    deposition of medication in the mouth and throat and makes metered dose
    inhalers easier for patients to use by reducing the need to coordinate
    actuation of the inhaler with inhalation. AeroChamber Plus(R) is the most
    widely prescribed holding chamber in the United States and has been used by
    millions of patients since its introduction. Approximately two thirds of
    AeroChamber Plus(R) Valved Holding Chamber prescriptions (IMS 2007 data) are
    written by pediatricians.

    “We are happy to strike this alliance with Forest. While the AeroChamber
    Plus(R) brand has a strong position in the Valved Holding Chamber market, we
    believe that this marketing alliance presents a significant opportunity for
    further growth of the franchise for Forest, resulting in value for both
    companies,” said Vinita Gupta, President, LPI.

    This agreement with Forest Laboratories, Inc. reflects Lupin’s commitment
    to bring value additions to the US market to improve the overall health of the
    patient population. This alliance will also extend Lupin’s presence in the
    respiratory segment and help strengthen its franchise with pediatricians.

    About Lupin

    Lupin Pharmaceuticals, Inc., headquartered in Baltimore, Maryland, is the
    wholly owned U.S. subsidiary of Mumbai based Lupin Limited, a leading Indian
    Pharmaceutical company. Lupin Limited develops, manufactures and markets a
    wide range of quality, affordable generic and branded generic formulations and
    APIs for the developed and the developing markets of the world. Twelve of
    Lupin’s facilities have been inspected and approved by the U.S. Food & Drug
    Administration.

    For the year ended March 2008, the Lupin’s consolidated Revenues and
    Profit after Tax were Rs. 27730 million (USD 660.23 million) and Rs. 4083
    million (USD 102 million) respectively.

    The Company has secured global leadership position in Anti-TB and
    Cephalosporins and has a significant presence in the areas of Cardiovasculars
    (prils and statins), Diabetology, Asthma and NSAIDs. Currently positioned
    amongst the top five pharmaceutical companies of India, the Company is
    committed to achieve sustainable earnings and growth for all its stakeholders.

    AeroChamber Plus(R) is a registered trademark of Trudell-Monaghan.

    For More Information:
    Lupin Pharmaceuticals, Inc.
    Contact: Atul Gokhale
    General Manager - Marketing
    410-576-2000
    Web site: http://www.lupinpharmaceuticals.com.

    SOURCE Lupin Pharmaceuticals, Inc.

  • 19Aug

    MUMBAI, India and BALTIMORE, Aug. 19 /PRNewswire/ — Lupin Ltd. announced
    today that the Company has entered into a multi-year promotion and marketing
    agreement for the AeroChamber Plus(R) line of products with Forest
    Laboratories, Inc. Under the terms of the agreement, Lupin Pharmaceuticals,
    Inc., USA, will use its 50 person sales force to promote the product to
    pediatricians.

    AeroChamber Plus(R) is a Valved Holding Chamber (VHC) device that is used
    with metered dose inhalers to improve the delivery of medication to the lungs
    in the treatment of asthma and COPD. AeroChamber Plus(R) also reduces the
    deposition of medication in the mouth and throat and makes metered dose
    inhalers easier for patients to use by reducing the need to coordinate
    actuation of the inhaler with inhalation. AeroChamber Plus(R) is the most
    widely prescribed holding chamber in the United States and has been used by
    millions of patients since its introduction. Approximately two thirds of
    AeroChamber Plus(R) Valved Holding Chamber prescriptions (IMS 2007 data) are
    written by pediatricians.

    “We are happy to strike this alliance with Forest. While the AeroChamber
    Plus(R) brand has a strong position in the Valved Holding Chamber market, we
    believe that this marketing alliance presents a significant opportunity for
    further growth of the franchise for Forest, resulting in value for both
    companies,” said Vinita Gupta, President, LPI.

    This agreement with Forest Laboratories, Inc. reflects Lupin’s commitment
    to bring value additions to the US market to improve the overall health of the
    patient population. This alliance will also extend Lupin’s presence in the
    respiratory segment and help strengthen its franchise with pediatricians.

    About Lupin

    Lupin Pharmaceuticals, Inc., headquartered in Baltimore, Maryland, is the
    wholly owned U.S. subsidiary of Mumbai based Lupin Limited, a leading Indian
    Pharmaceutical company. Lupin Limited develops, manufactures and markets a
    wide range of quality, affordable generic and branded generic formulations and
    APIs for the developed and the developing markets of the world. Twelve of
    Lupin’s facilities have been inspected and approved by the U.S. Food & Drug
    Administration.

    For the year ended March 2008, the Lupin’s consolidated Revenues and
    Profit after Tax were Rs. 27730 million (USD 660.23 million) and Rs. 4083
    million (USD 102 million) respectively.

    The Company has secured global leadership position in Anti-TB and
    Cephalosporins and has a significant presence in the areas of Cardiovasculars
    (prils and statins), Diabetology, Asthma and NSAIDs. Currently positioned
    amongst the top five pharmaceutical companies of India, the Company is
    committed to achieve sustainable earnings and growth for all its stakeholders.

    AeroChamber Plus(R) is a registered trademark of Trudell-Monaghan.

    For More Information:
    Lupin Pharmaceuticals, Inc.
    Contact: Atul Gokhale
    General Manager - Marketing
    410-576-2000
    Web site: http://www.lupinpharmaceuticals.com.

    SOURCE Lupin Pharmaceuticals, Inc.

« Previous Entries